| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.248 | 10.675 | 1.715 | 309 | 17.861 | 33.164 | 39.920 | 69.556 | 80.888 | 86.883 |
| Total Income - EUR | 7.253 | 10.677 | 1.715 | 309 | 17.866 | 33.164 | 39.920 | 69.556 | 81.009 | 86.903 |
| Total Expenses - EUR | 2.829 | 6.633 | 1.548 | 146 | 5.205 | 5.649 | 6.437 | 8.724 | 22.973 | 21.414 |
| Gross Profit/Loss - EUR | 4.424 | 4.045 | 167 | 163 | 12.661 | 27.515 | 33.482 | 60.832 | 58.036 | 65.489 |
| Net Profit/Loss - EUR | 4.206 | 3.725 | 115 | 154 | 12.125 | 26.634 | 32.309 | 59.199 | 57.242 | 62.934 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anisia Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 11.765 | 7.991 | 4.341 | 871 | 0 | 1.255 |
| Current Assets | 4.316 | 3.849 | 175 | 323 | 15.425 | 31.288 | 30.281 | 58.874 | 58.553 | 63.117 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 73 | 71 | 68 | 69 | 67 | 66 | 41.380 | 33.976 | 38.812 |
| Cash | 4.316 | 3.776 | 104 | 255 | 15.357 | 31.221 | 30.215 | 17.494 | 24.577 | 24.305 |
| Shareholders Funds | 4.251 | 3.778 | 168 | 318 | 12.440 | 38.838 | 32.359 | 59.250 | 57.292 | 62.984 |
| Social Capital | 45 | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 65 | 71 | 7 | 5 | 14.751 | 441 | 2.263 | 495 | 1.261 | 1.388 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anisia Med Srl